Abstract
Design: The attitudes of healthcare professionals and the lay public about genetic testing of children were elicited for a range of conditions through interviews with healthcare professionals and focus groups with parents. All participants were informed that behavioural genetic testing was the only hypothetical genetic test in our script and it was presented as the last condition.
Participants: The healthcare professionals included both genetic professionals and paediatricians. Focus group participants were recruited through various community institutions in the southside of Chicago and nearby suburbs.
Results: The healthcare professionals tended to medicalise behavioural genetics, and were opposed to testing unless treatment was available. They were also uniformly concerned about the potential harms of this information, including unintentional adverse effects from environmental changes. In contrast, parents wanted genetic testing for behavioural traits to be available even in the absence of proved medical treatments. Not all parents wanted to test their own children, and some parents were concerned about self-fulfilling prophecies. Some parents, however, felt the information was important for their understanding, and could be used to support environmental changes.
Conclusions: While healthcare professionals medicalised behavioural genetics, parents focused on environmental causes and influences. Consequently, healthcare professionals do not want to offer testing if there is no clear treatment, while parents may want this information to shape environmental influences.
Full Text
The Full Text of this article is available as a PDF (82.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brunner H. G. MAOA deficiency and abnormal behaviour: perspectives on an association. Ciba Found Symp. 1996;194:155–167. doi: 10.1002/9780470514825.ch9. [DOI] [PubMed] [Google Scholar]
- Brunner H. G., Nelen M., Breakefield X. O., Ropers H. H., van Oost B. A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science. 1993 Oct 22;262(5133):578–580. doi: 10.1126/science.8211186. [DOI] [PubMed] [Google Scholar]
- Campbell Elizabeth, Ross Lainie Friedman. Professional and personal attitudes about access and confidentiality in the genetic testing of children: a pilot study. Genet Test. 2003 Summer;7(2):123–130. doi: 10.1089/109065703322146803. [DOI] [PubMed] [Google Scholar]
- Clarke A. Parents' responses to predictive genetic testing in their children. J Med Genet. 1997 Feb;34(2):174–175. doi: 10.1136/jmg.34.2.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Craufurd D., Dodge A., Kerzin-Storrar L., Harris R. Uptake of presymptomatic predictive testing for Huntington's disease. Lancet. 1989 Sep 9;2(8663):603–605. doi: 10.1016/s0140-6736(89)90722-8. [DOI] [PubMed] [Google Scholar]
- Culliton Barbara J. XYY: Harvard researcher under fire stops newborn screening. Science. 1975 Jun 27;188(4195):1284–1285. doi: 10.1126/science.11643276. [DOI] [PubMed] [Google Scholar]
- Dalby S. GIG response to the UK Clinical Genetics Society report "The genetic testing of children". J Med Genet. 1995 Jun;32(6):490–491. doi: 10.1136/jmg.32.6.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hiller E. H., Landenburger G., Natowicz M. R. Public participation in medical policy-making and the status of consumer autonomy: the example of newborn-screening programs in the United States. Am J Public Health. 1997 Aug;87(8):1280–1288. doi: 10.2105/ajph.87.8.1280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jacobs P. A., Brunton M., Melville M. M., Brittain R. P., McClemont W. F. Aggressive behavior, mental sub-normality and the XYY male. Nature. 1965 Dec 25;208(5017):1351–1352. doi: 10.1038/2081351a0. [DOI] [PubMed] [Google Scholar]
- Kerr Anne, Cunningham-Burley Sarah, Amos Amanda. Drawing the line: an analysis of lay people's discussions about the new genetics. Public Underst Sci. 1998 Apr;7(2):113–133. doi: 10.1177/096366259800700202. [DOI] [PubMed] [Google Scholar]
- Lee Thomas H., Brennan Troyen A. Direct-to-consumer marketing of high-technology screening tests. N Engl J Med. 2002 Feb 14;346(7):529–531. doi: 10.1056/NEJM200202143460715. [DOI] [PubMed] [Google Scholar]
- Levitt D. M. Let the consumer decide? The regulation of commercial genetic testing. J Med Ethics. 2001 Dec;27(6):398–403. doi: 10.1136/jme.27.6.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Quaid K. A., Brandt J., Folstein S. E. The decision to be tested for Huntington's disease. JAMA. 1987 Jun 26;257(24):3362–3362. [PubMed] [Google Scholar]
- Robertson S., Savulescu J. Is there a case in favour of predictive genetic testing in young children? Bioethics. 2001 Feb;15(1):26–49. doi: 10.1111/1467-8519.00210. [DOI] [PubMed] [Google Scholar]
- Rose S. P. Neurogenetic determinism and the new euphenics. BMJ. 1998 Dec 19;317(7174):1707–1708. doi: 10.1136/bmj.317.7174.1707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schoenfeld M., Myers R. H., Berkman B., Clark E. Potential impact of a predictive test on the gene frequency of Huntington disease. Am J Med Genet. 1984 Jul;18(3):423–429. doi: 10.1002/ajmg.1320180311. [DOI] [PubMed] [Google Scholar]
- Steinfels Margaret O., Levine Carol. The XYY controversy: researching violence and genetics. Hastings Cent Rep. 1980 Aug 1;10(4):1–1. [PubMed] [Google Scholar]
- Stern R., Eldridge R. Attitudes of patients and their relatives to Huntington's disease. J Med Genet. 1975 Sep;12(3):217–223. doi: 10.1136/jmg.12.3.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Williams-Jones Bryn. Where there's a web, there's a way: commercial genetic testing and the Internet. Community Genet. 2003;6(1):46–57. doi: 10.1159/000069538. [DOI] [PubMed] [Google Scholar]
- Witkin Herman A., Goodenough Donald R., Hirschhorn Kurt. XYY men: are they criminally aggressive? Sciences (New York) 1977 Oct;17(6):10–13. doi: 10.1002/j.2326-1951.1977.tb01570.x. [DOI] [PubMed] [Google Scholar]